Taking the Long View: LA ART for HIV Treatment and Prevention

Download All
Learn with the experts about the latest data and developments on the current and future roles of long-acting ART in HIV treatment and prevention strategies. Listen to podcasts, read ClinicalThought faculty commentaries, download slidesets and patient education sheets, or watch the on-demand multimedia module of this engaging symposium.
Babafemi Taiwo, MBBS
Program Director
person default
Yvonne Gilleece, MB BCh, BAO
Cristina Mussini, MD
Babafemi Taiwo, MBBS
Darrell H. S. Tan, MD, FRCPC, PhD

Downloadable Slidesets

View these slides for an expert overview of available long-acting antiretroviral options for HIV treatment and pre-exposure prophylaxis, including data on safety, efficacy, and durability.

Babafemi Taiwo, MBBS
Program Director
Darrell H. S. Tan, MD, FRCPC, PhD
Released: June 14, 2022

View these slides for an expert review of practical insights into implementing long-acting ART regimens into HIV care, including addressing challenges for patient adherence and strategies to improve accessibility and convenience.

Babafemi Taiwo, MBBS
Program Director
Cristina Mussini, MD
Released: June 14, 2022

View these slides for an expert overview of long-acting agents and formulations currently under investigation for HIV treatment and pre-exposure prophylaxis.

Babafemi Taiwo, MBBS
Program Director
person default Yvonne Gilleece, MB BCh, BAO
Released: June 14, 2022

Podcasts

This podcast episode features an international panel discussion on the nuts and bolts of switching patients to long-acting injectable cabotegravir plus rilpivirine for HIV treatment.

person default Yvonne Gilleece, MB BCh, BAO Cristina Mussini, MD Babafemi Taiwo, MBBS Darrell H. S. Tan, MD, FRCPC, PhD Released: July 14, 2022

This podcast episode features an international panel discussion on clinic-level considerations for incorporating long-acting ART into the HIV treatment paradigm.

person default Yvonne Gilleece, MB BCh, BAO Cristina Mussini, MD Babafemi Taiwo, MBBS Darrell H. S. Tan, MD, FRCPC, PhD Released: August 2, 2022

This podcast episode features an international expert panel discussion on key considerations for using long-acting cabotegravir as HIV PrEP.

person default Yvonne Gilleece, MB BCh, BAO Cristina Mussini, MD Babafemi Taiwo, MBBS Darrell H. S. Tan, MD, FRCPC, PhD Released: September 9, 2022

ClinicalThought

Here’s my take on incorporating the available evidence to select the right patients for HIV treatment with long-acting injectable cabotegravir plus rilpivirine.

Cristina Mussini, MD Released: July 25, 2022

In this commentary, I share the factors I consider when deciding whether or not to recommend use of the optional 4-week oral lead-in before initiating long-acting cabotegravir plus rilpivirine injections and my thoughts on every-month vs every-2-month dosing.

Darrell H. S. Tan, MD, FRCPC, PhD Released: August 12, 2022

To extend long-acting PrEP to all potential candidates, we must improve our ability to reach individuals wherever they routinely access health services in the community. Here are my thoughts on the barriers we will need to address as we look to the future and the potential for bringing long-acting PrEP even closer to individuals who would benefit.

Babafemi Taiwo, MBBS
Program Director
Released: September 12, 2022

On-Demand Webcast

Watch and listen as a global panel of expert faculty provides insights on new long-acting approaches to HIV care through informative didactic presentations, patient perspectives, and engaging panel discussions.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings